Riskpilot← Back to searchSign inGet full accessAKLINIKKEN LØRENSKOG AS
ASActiveOrg 998704456Skårersletta 18, 1473 LørenskogAllmenn legetjeneste · NACE 86211Est. 20120 employees
Revenue 2022
NOK 1,7M
-42% vs 2021
EBITDA margin
-31.0%
-2904% vs 2021
Equity ratio
13.0%
Financial strength
Net profit 2022
NOK -483K
-194% vs 2021
| Revenue | NOK 1,7M | -42% |
| EBITDA | NOK -536K | -2904% |
| Net profit | NOK -483K | -194% |
| Total assets | NOK 597K | -66% |
| Equity | NOK 78K | -86% |
| Employees | 0 | — |
Legal name
AKLINIKKEN LØRENSKOG AS
Org number
998704456
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
13. august 2012
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive legevirksomhet, legesentervirksomhet, undervisning og rådgivning, konsulentvirksomhet, herunder å eie andeler og aksjer i andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Skårersletta 18, 1473 Lørenskog
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 2 737 | 4 780 | 5 049 | 3 008 | 1 733 |
| Staff expenses | −1 251 | −381 | −1 276 | −1 233 | −2 018 |
| EBITDA | −402 | 927 | 181 | −18 | −536 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −1 |
| EBIT | −402 | 927 | 181 | −18 | −537 |
| Net financials | −3 | 965 | −8 | 673 | 54 |
| Profit before tax | −404 | 1 892 | 173 | 655 | −483 |
| Tax | −97 | 337 | 36 | 140 | −0 |
| Net profit | −307 | 1 555 | 136 | 515 | −483 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 1 615 | 2 345 | 1 597 | 1 776 | 597 |
| Equity | −278 | 1 277 | 520 | 538 | 78 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 892 | 1 068 | 1 077 | 1 238 | 520 |
| Total debt | 1 892 | 1 068 | 1 077 | 1 238 | 520 |
EBITDA margin
-31.0%
This company
15.8%
Market median
-296% vs market
20182022
Equity ratio
13.0%
This company
38.2%
Market median
-66% vs market
20182022
Return on equity
-621.2%
This company
18.4%
Market median
-3476% vs market
20182022
Net profit margin
-27.9%
This company
8.1%
Market median
-444% vs market
20182022
Asset turnover
2.90×
This company
1.12×
Market median
+159% vs market
20182022
Debt / equity
6.68×
This company
0.62×
Market median
-977% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KH Deputy Member | Deputy Member | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AKLINIKKEN LØRENSKOG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristine Haaksvold Dahl | Deputy Member | 0 companies |
| Amir David Arden | Chairman | 0 companies |